Business Context and Reporting Period
This Form 6-K filing by Redhill Biopharma Ltd. is dated October 14, 2015. The report serves as a Notice to Shareholders regarding the upcoming Annual General Meeting scheduled for October 29, 2015. The filing addresses corrections to the proxy statement and voting procedures due to technical issues with the Israeli Securities Authority.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance notice and does not contain financial performance data.
Material Changes
The filing details two specific amendments to the previously issued Notice and Proxy Statement:
- Record Date Correction: A typographical error regarding the record date was corrected. The record date is confirmed as September 25, 2015. As of this date, the company had 127,029,294 Ordinary Shares outstanding, each entitled to one vote.
- Voting Method Restriction: Due to technical issues with filings by dual-listed companies, shareholders holding shares through members of the Tel Aviv Stock Exchange are unable to vote electronically via the Israel Securities Authority system. The text permitting this electronic voting method has been deleted from the proxy materials.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on business outlook, or discussion of general business risks. The primary contingency noted is the technical inability for certain shareholders to utilize the electronic voting system, necessitating alternative voting arrangements.
Key Facts for Investor Verification
- Verify the record date for voting eligibility is September 25, 2015.
- Confirm the total number of outstanding Ordinary Shares is 127,029,294.
- Shareholders holding shares via Tel Aviv Stock Exchange members must verify alternative voting instructions as electronic voting via the Israel Securities Authority is unavailable.
- Note the Annual General Meeting date is October 29, 2015.